Two glasses of cherry juice a day may reduce gut inflammation in bowel disease patients, study finds
Drinking two small glasses of cherry juice a day may reduce gut inflammation and boost quality of life in bowel disease ...
I Have Ulcerative Colitis and Used to Go to the Bathroom 20 Times a Day
Daniela Soto, 25, lives in Los Angeles and was diagnosed with ulcerative colitis (UC) when she was just 21. If you don’t know ...
Business Wire10h
Fresenius Continues Growth of Biosimilars Portfolio with the U.S. Availability of Otulfi ® (ustekinumab-aauz)
Fresenius Kabi, an operating company of Fresenius, and Formycon AG, a leading, independent developer of high-quality ...
Medscape3d
Anxiety, Depression, and Insufficient Exercise Linked to IBD Flare
The risk for both self-reported and symptomatic flare in inflammatory bowel disease is associated with psychosocial factors, ...
Medscape3d
Subcutaneous Guselkumab Proves Efficacious for IBD in Two Studies: ASTRO and GRAVITI
For both induction and maintenance therapy, subcutaneous guselkumab significantly improves clinical outcomes in patients with ...
Study Reveals the Food That's Particularly Bad for Your Gut Health
Doctors and nutritionists say you should limit these foods and beverages if you want to keep your digestive system happy and ...
Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn’s Disease and Ulcerative Colitis
Biomerica secures IVDR (In Vitro Diagnostic Regulation) certification, ensuring compliance with stringent European Union ...
emjreviews.com3d
Microbiome Dynamics Influence Faecal Microbiota Transplantation Efficacy in Ulcerative Colitis
FAECAL microbiota transplantation (FMT) shows promise in treating ulcerative colitis (UC), with specific gut microbial ...
appliedclinicaltrialsonline6d
New Data Emerges from Phase IIb RELIEVE UCCD Study in Ulcerative Colitis and Crohn’s Disease
Following initial positive results shared by Teva and Sanofi in December 2024, new data shows duvakitug (TEV’574/SAR447189) ...
Contract Pharma5h
Fresenius Kabi, Formycon Launch Otulfi in US
Otulfi, an ustekinumab biosimilar for the reference product Stelara (ustekinumab), developed by Formycon AG, is now available ...
manilatimes3d
TREMFYA® (guselkumab) receives positive CHMP opinion for treatment of adult patients with moderately to severely active ulcerative colitis
Recommendation based on the findings from the Phase 3 QUASAR programme in ulcerative colitis 1. Beerse, Belgium (28 February 2025) - Johnson & Johnson today announced that the Com ...